Approval of Glucosparc (metformin)
The pharmaceutical Glucosparc prolonged release tablet 500mg, 750mg and 1000mg, has been approved for sale in Sweden by the Medical Products Agency.Glucosparc is a prescription drug that is used to treat type 2 diabetes in adults where only exercise and diet are not enough to control blood sugar levels. Glucosparc may be used alone or combined with other drugs that lowers blood sugar. Glucosparc contains metformin, a substance that increases the effect of the body's own insulin, which in turn is needed for the body's cells to be able to get energy from glucose, the sugar that is absorbed